Crawford Fund Management LLC bought a new position in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 37,500 shares of the company's stock, valued at approximately $883,000. Crawford Fund Management LLC owned approximately 0.52% of Semler Scientific as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of SMLR. Cerity Partners LLC boosted its position in shares of Semler Scientific by 91.5% in the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company's stock valued at $31,689,000 after acquiring an additional 642,982 shares during the period. Shariaportfolio Inc. bought a new position in shares of Semler Scientific in the third quarter valued at approximately $3,618,000. AQR Capital Management LLC boosted its position in shares of Semler Scientific by 150.1% in the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company's stock valued at $4,833,000 after acquiring an additional 84,314 shares during the period. Dimensional Fund Advisors LP boosted its position in shares of Semler Scientific by 18.3% in the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company's stock valued at $4,341,000 after acquiring an additional 19,552 shares during the period. Finally, Citizens Financial Group Inc. RI bought a new stake in Semler Scientific during the second quarter valued at approximately $585,000. 49.37% of the stock is currently owned by institutional investors.
Semler Scientific Stock Performance
Semler Scientific stock traded down $4.03 during mid-day trading on Friday, hitting $57.02. 772,468 shares of the company traded hands, compared to its average volume of 260,612. Semler Scientific, Inc. has a one year low of $20.88 and a one year high of $79.45. The stock has a market cap of $472.70 million, a price-to-earnings ratio of 28.10 and a beta of 0.92. The stock has a fifty day moving average price of $35.16 and a 200-day moving average price of $31.74.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its earnings results on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The business had revenue of $13.51 million during the quarter.
Semler Scientific Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Stories
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
